{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:03:51Z","timestamp":1791475431548,"version":"4.3.4"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,25]],"date-time":"2020-05-25T00:00:00Z","timestamp":1590364800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,25]],"date-time":"2020-05-25T00:00:00Z","timestamp":1590364800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Institute of Nursing Research Intramural Program"},{"DOI":"10.13039\/100016156","name":"US Army Medical Research and Development Command","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100016156","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Concussion is the most common type of TBI, yet reliable objective measures related to these injuries and associated recovery processes remain elusive, especially in military personnel. The purpose of this study was to characterize the relationship between cytokines and recovery from acute brain injury in active duty service members. Inflammatory cytokines (IL-6, IL-10, and TNF\u03b1) were measured acutely in blood samples within 8\u2009h following a medically diagnosed concussion and then 24\u2009h later.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Participants (<jats:italic>n<\/jats:italic>\u2009=\u200994) were categorized into two groups: 1) military personnel who sustained provider-diagnosed concussion, without other major medical diagnosis (<jats:italic>n<\/jats:italic>\u2009=\u200945) and 2) healthy control participants in the same deployment environment who did not sustain concussion or other illness or injuries (<jats:italic>n<\/jats:italic>\u2009=\u200949). IL-6, IL-10, and TNF\u03b1 concentrations were measured using an ultrasensitive single-molecule enzyme-linked immunosorbent assay. Differences in cytokine levels between concussed and healthy groups were evaluated at two time points (time point 1\u2009\u2264\u20098\u2009h after injury; time point 2\u2009=\u200924\u2009h following time point 1).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>At time point 1, IL-6 median (IQR) concentrations were 2.62 (3.62) in the concussed group, which was greater compared to IL-6 in the healthy control group (1.03 (0.90); U\u2009=\u2009420.00, z\u2009=\u2009\u2212\u20095.12, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). Compared to healthy controls, the concussed group did not differ at time point 1 in IL-10 or TNF\u03b1 concentrations (<jats:italic>p<\/jats:italic>\u2019s\u2009&gt;\u20090.05). At time point 2, no differences were detected between concussed and healthy controls for IL-6, IL-10, or TNF\u03b1 (<jats:italic>p<\/jats:italic>\u2019s\u2009&gt;\u20090.05). The median difference between time points 1 and 2 were compared between the concussed and healthy control groups for IL-6, IL-10, and TNF\u03b1. Change in IL-6 across time was greater for the concussed group than healthy control (\u2212\u20091.54 (3.12); U\u2009=\u2009315.00, z\u2009=\u2009\u2212\u20095.96, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), with no differences between groups in the change of IL-10 or TNF\u03b1 (<jats:italic>p<\/jats:italic>\u2019s\u2009&gt;\u20090.05).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Reported here is a significant elevation of IL-6 levels in concussed military personnel less than 8\u2009h following injury. Future studies may examine acute and chronic neurological symptomology associated with inflammatory cytokine levels, distinguish individuals at high risk for developing neurological complications, and identify underlying biological pathways to mitigate inflammation and improve outcomes.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12883-020-01760-x","type":"journal-article","created":{"date-parts":[[2020,5,25]],"date-time":"2020-05-25T12:02:43Z","timestamp":1590408163000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Interleukin-6 is associated with acute concussion in military combat personnel"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7682-8598","authenticated-orcid":false,"given":"Katie A.","family":"Edwards","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica M.","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassandra L.","family":"Pattinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misha","family":"Bri\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Milhorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Elliot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Carr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,25]]},"reference":[{"issue":"11","key":"1760_CR1","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1176\/appi.ajp.2007.07071180","volume":"164","author":"E Jones","year":"2007","unstructured":"Jones E, Fear NT, Wessely S. Shell shock and mild traumatic brain injury: a historical review. Am J Psychiatry. 2007;164(11):1641\u20135.","journal-title":"Am J Psychiatry"},{"key":"1760_CR2","volume-title":"Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects","author":"RG DePalma","year":"2015","unstructured":"DePalma RG. Frontiers in Neuroengineering.Combat TBI: History, Epidemiology, and Injury Modes. In: Kobeissy FH, editor. Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects. Boca Raton: CRC Press\/Taylor & Francis.(c) 2015 by Taylor & Francis Group, LLC; 2015."},{"issue":"2","key":"1760_CR3","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1586\/14789450.5.2.283","volume":"5","author":"DA Prieto","year":"2008","unstructured":"Prieto DA, Ye X, Veenstra TD. Proteomic analysis of traumatic brain injury: the search for biomarkers. Expert Rev Proteomics. 2008;5(2):283\u201391.","journal-title":"Expert Rev Proteomics"},{"issue":"3","key":"1760_CR4","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.smrv.2007.07.007","volume":"12","author":"P Meerlo","year":"2008","unstructured":"Meerlo P, Sgoifo A, Suchecki D. Restricted and disrupted sleep: effects on autonomic function, neuroendocrine stress systems and stress responsivity. Sleep Med Rev. 2008;12(3):197\u2013210.","journal-title":"Sleep Med Rev"},{"issue":"7 Suppl","key":"1760_CR5","doi-asserted-by":"publisher","first-page":"S311","DOI":"10.1097\/CCM.0b013e31817e2a8c","volume":"36","author":"AE Ritenour","year":"2008","unstructured":"Ritenour AE, Baskin TW. Primary blast injury: update on diagnosis and treatment. Crit Care Med. 2008;36(7 Suppl):S311\u20137.","journal-title":"Crit Care Med"},{"issue":"22","key":"1760_CR6","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1056\/NEJMoa1008069","volume":"364","author":"CL Mac Donald","year":"2011","unstructured":"Mac Donald CL, Johnson AM, Cooper D, Nelson EC, Werner NJ, Shimony JS, et al. Detection of blast-related traumatic brain injury in U.S. military personnel. N Engl J Med. 2011;364(22):2091\u2013100.","journal-title":"N Engl J Med"},{"issue":"14","key":"1760_CR7","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1089\/neu.2016.4434","volume":"34","author":"Christine L. Mac Donald","year":"2017","unstructured":"Mac Donald CL, Johnson AM, Wierzechowski L, Kassner E, Stewart T, Nelson EC, et al. Outcome trends after US military concussive traumatic brain injury. J Neurotrauma. 2017;34(14):2206-19.","journal-title":"Journal of Neurotrauma"},{"issue":"8","key":"1760_CR8","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1001\/jamaneurol.2014.1114","volume":"71","author":"CL Mac Donald","year":"2014","unstructured":"Mac Donald CL, Johnson AM, Wierzechowski L, Kassner E, Stewart T, Nelson EC, et al. Prospectively assessed clinical outcomes in concussive blast vs nonblast traumatic brain injury among evacuated US military personnel. JAMA neurology. 2014;71(8):994\u20131002.","journal-title":"JAMA neurology"},{"issue":"1","key":"1760_CR9","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1097\/HTR.0000000000000064","volume":"30","author":"W Carr","year":"2015","unstructured":"Carr W, Polejaeva E, Grome A, Crandall B, LaValle C, Eonta SE, et al. Relation of repeated low-level blast exposure with symptomology similar to concussion. J Head Trauma Rehabil. 2015;30(1):47\u201355.","journal-title":"J Head Trauma Rehabil"},{"issue":"9","key":"1760_CR10","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/S1474-4422(18)30231-X","volume":"17","author":"JJ Bazarian","year":"2018","unstructured":"Bazarian JJ, Biberthaler P, Welch RD, Lewis LM, Barzo P, Bogner-Flatz V, et al. Serum GFAP and UCH-L1 for prediction of absence of intracranial injuries on head CT (ALERT-TBI): a multicentre observational study. Lancet Neurol. 2018;17(9):782\u20139.","journal-title":"Lancet Neurol"},{"issue":"1","key":"1760_CR11","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1097\/TA.0000000000000468","volume":"78","author":"HE Hinson","year":"2015","unstructured":"Hinson HE, Rowell S, Schreiber M. Clinical evidence of inflammation driving secondary brain injury: a systematic review. J Trauma Acute Care Surg. 2015;78(1):184\u201391.","journal-title":"J Trauma Acute Care Surg"},{"key":"1760_CR12","doi-asserted-by":"publisher","first-page":"528","DOI":"10.3389\/fncel.2019.00528","volume":"13","author":"SY Ng","year":"2019","unstructured":"Ng SY, Lee AYW. Traumatic brain injuries: pathophysiology and potential therapeutic targets. Front Cell Neurosci. 2019;13:528.","journal-title":"Front Cell Neurosci"},{"issue":"10","key":"1760_CR13","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.3109\/02699052.2014.916818","volume":"28","author":"LC Ferreira","year":"2014","unstructured":"Ferreira LC, Regner A, Miotto KD, Moura S, Ikuta N, Vargas AE, et al. Increased levels of interleukin-6, \u22128 and \u221210 are associated with fatal outcome following severe traumatic brain injury. Brain Inj. 2014;28(10):1311\u20136.","journal-title":"Brain Inj"},{"issue":"2","key":"1760_CR14","first-page":"339","volume":"52","author":"C Woiciechowsky","year":"2002","unstructured":"Woiciechowsky C, Schoning B, Cobanov J, Lanksch WR, Volk HD, Docke WD. Early IL-6 plasma concentrations correlate with severity of brain injury and pneumonia in brain-injured patients. J Trauma. 2002;52(2):339\u201345.","journal-title":"J Trauma"},{"issue":"6","key":"1760_CR15","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/HTR.0000000000000067","volume":"30","author":"RG Kumar","year":"2015","unstructured":"Kumar RG, Boles JA, Wagner AK. Chronic inflammation after severe traumatic brain injury: characterization and associations with outcome at 6 and 12 months Postinjury. J Head Trauma Rehabil. 2015;30(6):369\u201381.","journal-title":"J Head Trauma Rehabil"},{"key":"1760_CR16","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3389\/fneur.2016.00189","volume":"7","author":"F Licastro","year":"2016","unstructured":"Licastro F, Hrelia S, Porcellini E, Malaguti M, Di Stefano C, Angeloni C, et al. Peripheral inflammatory markers and antioxidant response during the post-acute and chronic phase after severe traumatic brain injury. Front Neurol. 2016;7:189.","journal-title":"Front Neurol"},{"key":"1760_CR17","doi-asserted-by":"publisher","first-page":"556","DOI":"10.3389\/fimmu.2016.00556","volume":"7","author":"CA McKee","year":"2016","unstructured":"McKee CA, Lukens JR. Emerging roles for the immune system in traumatic brain injury. Front Immunol. 2016;7:556.","journal-title":"Front Immunol"},{"key":"1760_CR18","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3389\/fneur.2013.00018","volume":"4","author":"T Woodcock","year":"2013","unstructured":"Woodcock T, Morganti-Kossmann MC. The role of markers of inflammation in traumatic brain injury. Front Neurol. 2013;4:18.","journal-title":"Front Neurol"},{"issue":"2","key":"1760_CR19","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/S0014-4886(02)00051-1","volume":"181","author":"M Penkowa","year":"2003","unstructured":"Penkowa M, Giralt M, Lago N, Camats J, Carrasco J, Hernandez J, et al. Astrocyte-targeted expression of IL-6 protects the CNS against a focal brain injury. Exp Neurol. 2003;181(2):130\u201348.","journal-title":"Exp Neurol"},{"issue":"3","key":"1760_CR20","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/1098-1136(200012)32:3<271::AID-GLIA70>3.0.CO;2-5","volume":"32","author":"M Penkowa","year":"2000","unstructured":"Penkowa M, Giralt M, Carrasco J, Hadberg H, Hidalgo J. Impaired inflammatory response and increased oxidative stress and neurodegeneration after brain injury in interleukin-6-deficient mice. Glia. 2000;32(3):271\u201385.","journal-title":"Glia."},{"issue":"1\u20132","key":"1760_CR21","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/S0006-8993(02)02458-7","volume":"937","author":"AE Kline","year":"2002","unstructured":"Kline AE, Bolinger BD, Kochanek PM, Carlos TM, Yan HQ, Jenkins LW, et al. Acute systemic administration of interleukin-10 suppresses the beneficial effects of moderate hypothermia following traumatic brain injury in rats. Brain Res. 2002;937(1\u20132):22\u201331.","journal-title":"Brain Res"},{"issue":"4","key":"1760_CR22","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s004230100204","volume":"386","author":"M Arand","year":"2001","unstructured":"Arand M, Melzner H, Kinzl L, Bruckner UB, Gebhard F. Early inflammatory mediator response following isolated traumatic brain injury and other major trauma in humans. Langenbeck's Arch Surg. 2001;386(4):241\u20138.","journal-title":"Langenbeck's Arch Surg"},{"key":"1760_CR23","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12974-016-0500-3","volume":"13","author":"AP Di Battista","year":"2016","unstructured":"Di Battista AP, Rhind SG, Hutchison MG, Hassan S, Shiu MY, Inaba K, et al. Inflammatory cytokine and chemokine profiles are associated with patient outcome and the hyperadrenergic state following acute brain injury. J Neuroinflammation. 2016;13:40.","journal-title":"J Neuroinflammation"},{"issue":"2","key":"1760_CR24","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/jcbfm.2010.142","volume":"31","author":"A Helmy","year":"2011","unstructured":"Helmy A, Carpenter KL, Menon DK, Pickard JD, Hutchinson PJ. The cytokine response to human traumatic brain injury: temporal profiles and evidence for cerebral parenchymal production. J Cereb Blood Flow Metab. 2011;31(2):658\u201370.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1760_CR25","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1742-2094-7-19","volume":"7","author":"GW Hergenroeder","year":"2010","unstructured":"Hergenroeder GW, Moore AN, McCoy JP Jr, Samsel L, Ward NH 3rd, Clifton GL, et al. Serum IL-6: a candidate biomarker for intracranial pressure elevation following isolated traumatic brain injury. J Neuroinflammation. 2010;7:19.","journal-title":"J Neuroinflammation"},{"issue":"3","key":"1760_CR26","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/HTR.0000000000000031","volume":"30","author":"SB Juengst","year":"2015","unstructured":"Juengst SB, Kumar RG, Failla MD, Goyal A, Wagner AK. Acute inflammatory biomarker profiles predict depression risk following moderate to severe traumatic brain injury. J Head Trauma Rehabil. 2015;30(3):207\u201318.","journal-title":"J Head Trauma Rehabil"},{"issue":"3","key":"1760_CR27","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.imbio.2015.11.011","volume":"221","author":"T Lustenberger","year":"2016","unstructured":"Lustenberger T, Kern M, Relja B, Wutzler S, Stormann P, Marzi I. The effect of brain injury on the inflammatory response following severe trauma. Immunobiology. 2016;221(3):427\u201331.","journal-title":"Immunobiology."},{"issue":"1","key":"1760_CR28","doi-asserted-by":"publisher","first-page":"e18357","DOI":"10.5812\/atr.18357","volume":"4","author":"S Yousefzadeh-Chabok","year":"2015","unstructured":"Yousefzadeh-Chabok S, Dehnadi Moghaddam A, Kazemnejad-Leili E, Saneei Z, Hosseinpour M, Kouchakinejad-Eramsadati L, et al. The relationship between serum levels of interleukins 6, 8, 10 and clinical outcome in patients with severe traumatic brain injury. Arch Trauma Res. 2015;4(1):e18357.","journal-title":"Arch Trauma Res"},{"issue":"6","key":"1760_CR29","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1159\/000342141","volume":"19","author":"FM Schneider Soares","year":"2012","unstructured":"Schneider Soares FM, Menezes de Souza N, Liborio Schwarzbold M, Paim Diaz A, Costa Nunes J, Hohl A, et al. Interleukin-10 is an independent biomarker of severe traumatic brain injury prognosis. Neuroimmunomodulation. 2012;19(6):377\u201385.","journal-title":"Neuroimmunomodulation."},{"issue":"5","key":"1760_CR30","doi-asserted-by":"publisher","first-page":"e497","DOI":"10.1212\/WNL.0000000000007864","volume":"93","author":"ME Nitta","year":"2019","unstructured":"Nitta ME, Savitz J, Nelson LD, Teague TK, Hoelzle JB, McCrea MA, et al. Acute elevation of serum inflammatory markers predicts symptom recovery after concussion. Neurology. 2019;93(5):e497\u2013507.","journal-title":"Neurology."},{"key":"1760_CR31","doi-asserted-by":"crossref","unstructured":"Devoto C, Arcurio L, Fetta J, Ley M, Rodney T, Kanefsky RZ, et al. Inflammation relates to chronic behavioral and neurological symptoms in military with traumatic brain injuries. Cell Transplant. 2016;26(7):1169-77.","DOI":"10.1177\/0963689717714098"},{"issue":"1","key":"1760_CR32","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12974-019-1402-y","volume":"16","author":"AP Di Battista","year":"2019","unstructured":"Di Battista AP, Churchill N, Rhind SG, Richards D, Hutchison MG. Evidence of a distinct peripheral inflammatory profile in sport-related concussion. J Neuroinflammation. 2019;16(1):17.","journal-title":"J Neuroinflammation"},{"key":"1760_CR33","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.3389\/fneur.2019.01120","volume":"10","author":"Y Sun","year":"2019","unstructured":"Sun Y, Bai L, Niu X, Wang Z, Yin B, Bai G, et al. Elevated serum levels of inflammation-related cytokines in mild traumatic brain injury are associated with cognitive performance. Front Neurol. 2019;10:1120.","journal-title":"Front Neurol"},{"key":"1760_CR34","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.bbi.2017.02.015","volume":"65","author":"J Gill","year":"2017","unstructured":"Gill J, Motamedi V, Osier N, Dell K, Arcurio L, Carr W, et al. Moderate blast exposure results in increased IL-6 and TNFalpha in peripheral blood. Brain Behav Immun. 2017;65:90\u20134.","journal-title":"Brain Behav Immun"},{"issue":"11","key":"1760_CR35","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1016\/j.apmr.2010.05.017","volume":"91","author":"DK Menon","year":"2010","unstructured":"Menon DK, Schwab K, Wright DW, Maas AI. Position statement: definition of traumatic brain injury. Arch Phys Med Rehabil. 2010;91(11):1637\u201340.","journal-title":"Arch Phys Med Rehabil"},{"key":"1760_CR36","volume-title":"DoD policy guidance for management of mild traumatic brain injury\/concussion in the deployed setting","author":"E Conaton","year":"2012","unstructured":"Conaton E. DoD policy guidance for management of mild traumatic brain injury\/concussion in the deployed setting. Washington: Department of Defense; 2012."},{"key":"1760_CR37","doi-asserted-by":"publisher","first-page":"6446","DOI":"10.1038\/srep06446","volume":"4","author":"S Mondello","year":"2014","unstructured":"Mondello S, Buki A, Barzo P, Randall J, Provuncher G, Hanlon D, et al. CSF and plasma amyloid-beta temporal profiles and relationships with neurological status and mortality after severe traumatic brain injury. Sci Rep. 2014;4:6446.","journal-title":"Sci Rep"},{"key":"1760_CR38","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3389\/fneur.2013.00030","volume":"4","author":"DG Hernandez-Ontiveros","year":"2013","unstructured":"Hernandez-Ontiveros DG, Tajiri N, Acosta S, Giunta B, Tan J, Borlongan CV. Microglia activation as a biomarker for traumatic brain injury. Front Neurol. 2013;4:30.","journal-title":"Front Neurol"},{"key":"1760_CR39","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3389\/fneur.2017.00244","volume":"8","author":"JM Garcia","year":"2017","unstructured":"Garcia JM, Stillings SA, Leclerc JL, Phillips H, Edwards NJ, Robicsek SA, et al. Role of Interleukin-10 in acute brain injuries. Front Neurol. 2017;8:244.","journal-title":"Front Neurol"},{"issue":"2","key":"1760_CR40","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.jss.2011.03.006","volume":"170","author":"EJ Ley","year":"2011","unstructured":"Ley EJ, Clond MA, Singer MB, Shouhed D, Salim A. IL6 deficiency affects function after traumatic brain injury. J Surg Res. 2011;170(2):253\u20136.","journal-title":"J Surg Res"},{"issue":"3","key":"1760_CR41","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1002\/ana.22455","volume":"70","author":"AF Ramlackhansingh","year":"2011","unstructured":"Ramlackhansingh AF, Brooks DJ, Greenwood RJ, Bose SK, Turkheimer FE, Kinnunen KM, et al. Inflammation after trauma: microglial activation and traumatic brain injury. Ann Neurol. 2011;70(3):374\u201383.","journal-title":"Ann Neurol"},{"issue":"6","key":"1760_CR42","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1097\/SHK.0000000000000037","volume":"40","author":"SH Yang","year":"2013","unstructured":"Yang SH, Gangidine M, Pritts TA, Goodman MD, Lentsch AB. Interleukin 6 mediates neuroinflammation and motor coordination deficits after mild traumatic brain injury and brief hypoxia in mice. Shock (Augusta, Ga). 2013;40(6):471\u20135.","journal-title":"Shock (Augusta, Ga)"},{"issue":"3","key":"1760_CR43","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1089\/neu.2009.1120","volume":"27","author":"T Frugier","year":"2010","unstructured":"Frugier T, Morganti-Kossmann MC, O'Reilly D, McLean CA. In situ detection of inflammatory mediators in post mortem human brain tissue after traumatic injury. J Neurotrauma. 2010;27(3):497\u2013507.","journal-title":"J Neurotrauma"},{"key":"1760_CR44","doi-asserted-by":"publisher","first-page":"520258","DOI":"10.1155\/2010\/520258","volume":"2010","author":"C Brandt","year":"2010","unstructured":"Brandt C, Pedersen BK. The role of exercise-induced myokines in muscle homeostasis and the defense against chronic diseases. J Biomed Biotechnol. 2010;2010:520258.","journal-title":"J Biomed Biotechnol"},{"key":"1760_CR45","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.neuroscience.2013.11.036","volume":"266","author":"X Chen","year":"2014","unstructured":"Chen X, Duan XS, Xu LJ, Zhao JJ, She ZF, Chen WW, et al. Interleukin-10 mediates the neuroprotection of hyperbaric oxygen therapy against traumatic brain injury in mice. Neuroscience. 2014;266:235\u201343.","journal-title":"Neuroscience."},{"issue":"1","key":"1760_CR46","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s10753-016-0457-5","volume":"40","author":"R Zou","year":"2017","unstructured":"Zou R, Li D, Wang G, Zhang M, Zhao Y, Yang Z. TAZ activator is involved in IL-10-mediated muscle responses in an animal model of traumatic brain injury. Inflammation. 2017;40(1):100\u20135.","journal-title":"Inflammation."},{"issue":"1","key":"1760_CR47","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12974-017-0843-4","volume":"14","author":"JP Barrett","year":"2017","unstructured":"Barrett JP, Henry RJ, Villapol S, Stoica BA, Kumar A, Burns MP, et al. NOX2 deficiency alters macrophage phenotype through an IL-10\/STAT3 dependent mechanism: implications for traumatic brain injury. J Neuroinflammation. 2017;14(1):65.","journal-title":"J Neuroinflammation"},{"issue":"3","key":"1760_CR48","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1097\/JSA.0000000000000117","volume":"24","author":"L Papa","year":"2016","unstructured":"Papa L. Potential blood-based biomarkers for concussion. Sports Med Arthrosc Rev. 2016;24(3):108\u201315.","journal-title":"Sports Med Arthrosc Rev"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-020-01760-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-020-01760-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-020-01760-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T23:12:42Z","timestamp":1621897962000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-020-01760-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,25]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1760"],"URL":"https:\/\/doi.org\/10.1186\/s12883-020-01760-x","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,25]]},"assertion":[{"value":"16 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the Walter Reed Army Institute of Research Institutional Review Boards and investigators adhered to the policies for protection of human subjects as prescribed in AR 70\u201325 and all applicable Federal regulations governing the protection of human subjects. Each study participant provided written informed consent for participation.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The opinions and assertions in this manuscript are those of the authors and are not to be construed as official as reflecting true views of the Department of Navy, Department of the Air Force, Department of the Army, Department of Defense, the Uniformed Services University of the Health Sciences, U.S. Government, the Center for Neuroscience and Regenerative Medicine or any other agency of the U.S. government. Some of the authors are military service members or employees of the U.S. Government. This work was prepared as part of their official duties. Title 17\u2009U.S.C. \u00a7105 provides that \u2018Copyright protection under this title is not available for any work of the United States Government.\u2019 Title 17\u2009U.S.C. \u00a7101 defines a U.S. Government work as a work prepared by a military service member or employee of the U.S. Government as part of that person\u2019s official duties. Material has been reviewed by the Walter Reed Army Institute of Research. There is no objection to its presentation and\/or publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"209"}}